Exclusive

Exclusive Lizzy Lawrence, Elaine Chen, and Damian Garde

STAT Plus: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment

Exclusive Lizzy Lawrence

STAT Plus: FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program

Exclusive Brittany Trang

STAT Plus: AI biotech founded by ex-Google CEO Eric Schmidt is raising $150 million

Exclusive Jason Mast

STAT Plus: Startup Altido Therapeutics pursues CAR-T for glioblastoma tumors 

Exclusive Isabella Cueto

STAT Plus: Behind new dietary guidelines: Industry-funded studies, opaque science, crushing deadline pressure

Exclusive Jonathan Wosen

STAT Plus: Illumina launches massive cell atlas to fast-track drug discovery

Exclusive Isabella Cueto and Sarah Todd

STAT Plus: Panel behind new dietary guidelines had financial ties to beef, dairy industries

Exclusive Jonathan Wosen

STAT Plus: Director of NIH neurological disorders institute is ousted, adding to leadership churn

Exclusive Daniel Payne

STAT Plus: Kennedy vaccine adviser to take a new role at CDC on children’s health research

Exclusive Lizzy Lawrence

STAT Plus: FDA voucher program has become vehicle for political interference in drug review decisions, staffers say

Exclusive Anil Oza

STAT Plus: NIH specifies how grant reviewers should ensure alignment with Trump priorities

A STAT Examination Lizzy Lawrence

STAT Plus: FDA staff fear Tracy Beth Høeg will bring bias and instability to embattled drug center

Exclusive Lev Facher

STAT Plus: Acting head of beleaguered mental health agency to depart this week

Exclusive Allison DeAngelis

STAT Plus: Hengrui, BeOne top new analysis of Chinese drug development

Exclusive Lizzy Lawrence

STAT Plus: FDA to lower number of trials required for approval of drugs, other medical products

Exclusive Lizzy Lawrence

STAT Plus: FDA removes longtime over-the-counter drugs regulator from her position

Exclusive Daniel Payne

STAT Plus: Independent doctors get a new advocacy group as skepticism of health giants grows

Exclusive Allison DeAngelis

STAT Plus: Aging startup backed by Sam Altman chases $5 billion valuation

Exclusive Lizzy Lawrence

STAT Plus: Top drug regulator Richard Pazdur set to leave the FDA

Exclusive O. Rose Broderick

STAT Plus: CDC staff with disabilities feel stranded as HHS implements new policy

Exclusive Bob Herman

STAT Plus: Major health insurers like Humana, UnitedHealth are cutting broker commissions to avoid costly Medicare enrollees

Exclusive Allison DeAngelis

STAT Plus: Federal biotech commission calls for retooling of scientific research infrastructure

Exclusive O. Rose Broderick

STAT Plus: CDC moves to end telework for employees, including those with medical needs

Exclusive Lizzy Lawrence

STAT Plus: FDA review staff was excluded from voting on whether to approve first priority voucher drug

Exclusive Casey Ross

STAT Plus: AI spun out of Berkeley proposes to detect hundreds of conditions on medical images

Exclusive Damian Garde

STAT Plus: AbbVie cuts ties with Google-backed longevity company, lays off scientists

Exclusive Lizzy Lawrence

STAT Plus: How two top FDA officials are quietly upending vaccine regulations

Exclusive Lizzy Lawrence

STAT Plus: FDA broadens search for new top drug regulator after early setbacks 

Exclusive Brittany Trang

STAT Plus: Medicare picks tech vendors to run AI prior authorization pilot in six states